RecruitingNot ApplicableNCT06995690

Ketamine for Preventing Post-Spinal Hypotension in Orthopedic Surgery

Impact of Sub-anesthetic Dose of Ketamine in the Prevention of Post Spinal Hypotension in Patients Undergoing Orthopedic Surgeries


Sponsor

Ain Shams University

Enrollment

30 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized, double-blind, controlled clinical trial investigates the efficacy of a sub-anesthetic dose of ketamine (0.5 mg/kg IV) in preventing post-spinal hypotension in patients undergoing elective orthopedic surgeries under spinal anesthesia. The study compares ketamine with placebo (normal saline) in terms of blood pressure stability and incidence of hypotensive episodes following spinal anesthesia.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients American Society of Anesthesiologists Physical Status (ASA) I to II undergoing orthopedic surgeries under spinal anesthesia.
  • Both Sexes.
  • Patients aged equal to or above 18 years.
  • Body mass index \<35 kg/m2
  • Duration of operation from 1 hour to 3 hours

Exclusion Criteria6

  • Patients' refusal of procedure or participation in the study.
  • Patients with contraindication to spinal anesthesia.
  • Patients with cardiovascular or pulmonary disease.
  • Patients with pre-procedural hypotension (systolic arterial pressure less than 90 mmHg and/or mean arterial pressure less than 60 mmHg).
  • Patients aged below 18 years.
  • Duration of operation below 1 hour or above 3 hours.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Patients receive crystalloid preloading of 15ml/kg (Ringer's lactate) +the sub-anesthetic dose of ketamine of 0.5 mg/kg IV added to the first bottle of ringer for blinding over 20 min before the spinal injection.

DRUGNormal Saline

Patients receive a crystalloid preloading of 15 ml/kg (Ringer's lactate)+ 0.5 mg/kg IV of Normal Saline added to the first bottle of ringer for blinding, over 20 min before the spinal injection.


Locations(1)

Ain Shams University Hospitals

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06995690


Related Trials